News
Antevia Networks deploys 5G private network at Bath Rugby stadium
Antevia Networks, the telecoms equipment vendor changing the economics of 5G private networks, has announced the successful deployment of its 5G Shift end-to-end private network at Premiership Rugby Champions Bath Rugby's historic Recreation Ground. The new 5G private network delivers low-cost, high-performance, predictable connectivity across the entire stadium and fan
Read More
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
Eli Lilly and Company (NYSE: LLY) and Ventyx Biosciences, Inc. (Nasdaq: VTYX), a San Diego-based clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammatory-mediated diseases, have announced entry into a definitive agreement for Lilly to acquire Ventyx. Ventyx is developing a pipeline of small molecule therapeutics,
Read More
Paragraf produces first 6-inch graphene wafer at new Huntingdon facility
Paragraf, the UK-based company pioneering the commercialization of graphene-based electronics using standard semiconductor processes, has successfully produced the first 6-inch wafer at its new manufacturing facility in Huntingdon, marking a significant expansion in the company’s production capability and technology platform. The wafer contains graphene field-effect transistors (GFETs) fabricated using Paragraf’s
Read More
Long Wall announces Cyclops: the mass-producible interceptor
Long Wall has announced Cyclops: a new, surface-launched, exoatmospheric interceptor to defeat missiles in the midcourse phase of flight. Cyclops will provide high-performance, low-cost magazine depth for homeland and regional missile defense. A mission to defer and defeat As Long Wall’s flagship interceptor, Cyclops underpins our mission to accelerate missile
Read More
Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment NVD003 in congenital pseudoarthrosis of the tibia
Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has announced the recruitment of the first pediatric patients for the pivotal phase 3 trial of its tissue regeneration product NVD003 in congenital pseudoarthrosis of the tibia (CPT). Phoenix Children’s Hospital, (Phoenix, AZ, USA), and Cliniques universitaires Saint-Luc, (Brussels,
Read MoreVentyx provides clinical and corporate updates
Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammation-mediated cardiovascular and neurodegenerative diseases, has announced that the Company added two leading experts to their advisory board and provided an update to its ongoing Phase 2 study of VTX2735
Read More
Resolve Therapeutics to present at International Symposium on Circulating Nucleic Acids in Plasma and Serum (CNAPS)
Resolve Therapeutics, a mid-stage clinical biopharmaceutical company pioneering non-immunosuppressive drugs for inflammatory diseases has announced it will highlight its platform and clinical progress in a presentation entitled “Cell-free Nucleic Acids as Drug Targets in Autoimmunity and Acute Brain Injury”. Dr. James Posada, chief executive officer of Resolve Therapeutics will present
Read More
VORAGO shatters satellite electronics barriers, launching radiation-tolerant chips to power the next generation of satellite constellations
The booming satellite industry just received a massive cost-saving injection paired with unprecedented ease of integration. VORAGO Technologies has announced a world first: the launch of four radiation-tolerant microcontrollers purpose-built for low Earth orbit (LEO) markets at a fraction of the cost of traditional space-grade components, with first chips shipping
Read More
Abu Dhabi Investment Office partners with Glydways to bring transformative autonomous transit technology
Abu Dhabi Investment Office (ADIO) has signed a strategic partnership with Glydways, Inc. (Glydways) a leading global Automated Transit Network (ATN), to explore the deployment of its innovative transit systems across Abu Dhabi. The collaboration, which builds on momentum from the recent Abu Dhabi Investment Forum in New York, marks
Read More
Zeotap awarded ISO 27001 Certification for Information Security Management
Zeotap, the next-generation Customer Data Platform (CDP), has been awarded the ISO/IEC 27001 certification after meeting the stringent requirements for establishing, implementing, maintaining and continually improving an information security management system (ISMS) as put forward by the International Organization for Standardization (ISO). Zeotap India has been awarded the certification for
Read MoreInternational Open RAN vendors to scale advanced connectivity solutions in the UK
Digital Catapult has welcomed six international Open RAN (Radio Access Network) vendors to its advanced connectivity programme, driving the development, deployment and diversification of data-driven and open future networks in the UK. The next phase of the programme will support vendors to trial real-world products and services for scaling and
Read MoreVentyx Biosciences announces positive topline results from Phase 2 study of VTX3232 in participants with obesity and cardiovascular risk factors
Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), has announced positive results from its Phase 2 study of oral, once-daily VTX3232 in patients with Obesity and Cardiovascular Risk Factors. The 175- participant study examined VTX3232 versus placebo, alone or in combination with semaglutide, evaluating safety and tolerability as the primary endpoint,
Read More